GlassScriptPhysician profile
John P Campbell
NPI 1194220657
$2,109.89
in general payments reported to CMS, 2019-2025
17 companies · $292 in 2025
The $292 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $101 · 2022: $102 · 2023: $1,196 · 2024: $294 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768 · Travel and Lodging: $646 · Long Term Medical Supply Or Device Loan: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.31 |
| Travel and Lodging | $646.23 |
| Long Term Medical Supply Or Device Loan | $367.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wilson Cook Medical Incorporated | $645.25 | 2023 | Fusion |
| Pentax of America, INC. | $367.88 | 2023 | Video Gastroscope |
| Gilead Sciences, INC. | $238.61 | 2019-2024 | Epclusa |
| Abbvie INC. | $177.86 | 2023-2025 | Rinvoq, Skyrizi |
| Olympus America INC. | $150.44 | 2024-2025 | Endoclot Phs, Gastrointestinal Videoscope, Evis Exera III Video System Center |
| Genzyme Corporation | $125.26 | 2023 | |
| Medtronic, INC. | $101.82 | 2022 | |
| Intercept Pharmaceuticals, INC. | $100.65 | 2021 | |
| Janssen Biotech, INC. | $41.98 | 2025 | Tremfya |
| Viiv Healthcare Company | $26.29 | 2023 | Rukobia |
| Pharmacosmos Therapeutics INC. | $24.77 | 2025 | Monoferric |
| Scpharmaceuticals INC. | $23.76 | 2025 | |
| Invivyd INC | $23.74 | 2025 | Pemgarda |
| Cook Medical LLC | $18.38 | 2023 | Hemospray |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.98 | 2025 | Xifaxan |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $15.39 | 2024 | Ibsrela |
| Micro-Tech Endoscopy USA, INC. | $10.83 | 2024 | Lesionhunter, Lockado |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.